SLF1 (SMC5/6 complex localization factor 1) is a critical regulator of DNA damage response and genome stability maintenance. Its primary function is to facilitate recruitment of the SMC5/6 complex to DNA lesions, particularly at replication-coupled interstrand cross-links (ICL) and double-strand breaks (DSBs) 1. SLF1 achieves this through a multi-domain architecture: its ankyrin repeat domain binds unmethylated histone H4 tails on nascent nucleosomes, while its tandem BRCT domain interacts phosphorylation-dependently with RAD18 (S442/S444 phosphorylation sites), forming the SLF1-SLF2 complex that bridges RAD18 to SMC5/6 at stalled replication forks 2. SLF1 also possesses intrinsic DNA-binding capacity that enhances nucleosome recognition 2. Functionally, SLF1 promotes homologous recombination repair by enabling RAD18-mediated recruitment of SMC5/6 to DSBs while suppressing non-homologous end joining 3. Clinical relevance is underscored by mutations in SLF2 and SMC5—the latter functioning with SLF1 in the RAD18-SLF1/2-SMC5/6 pathway—causing Atelís Syndrome, characterized by segmented/dicentric chr5, mosaic variegated hyperploidy, elevated replication stress, and loss of sister chr5 cohesion 4. Additionally, RAD18 loss-of-function mutations identified in cancer patients suggest SLF1's pathway involvement in cancer development 3.